University of California: Study Could Help Explain Why Certain Brain Tumors Don't Respond Well to Immunotherapy
September 02, 2023
September 02, 2023
LOS ANGELES, California, Sept. 2 (TNSres) -- The University of California issued the following news release:
* * *
Immune checkpoint blockade has been ineffective for treating glioblastoma; UCLA-led research may reveal why
Key takeaways
* Immunotherapy has been effective in treating certain types of cancer, including those that spread into the brain. But it has little effect in fighting glioblastoma, an aggressive cancer that originates in the . . .
* * *
Immune checkpoint blockade has been ineffective for treating glioblastoma; UCLA-led research may reveal why
Key takeaways
* Immunotherapy has been effective in treating certain types of cancer, including those that spread into the brain. But it has little effect in fighting glioblastoma, an aggressive cancer that originates in the . . .